Congressional Inquiry into Alzheimer’s Drug Faults Its Maker and F.D.A.

By BY PAM BELLUCK from NYT Health https://ift.tt/weErOq6
via IFTTT
Health
Drugs (Pharmaceuticals), Alzheimer's Disease, Clinical Trials, Labeling and Labels (Product), Aduhelm (Drug), Advertising and Marketing, Elderly
New York Times
December 29, 2022 at 11:30PM